Acinetobacter baumannii is a major cause of healthcare-associated infection, often affecting
critically ill patients. The purpose of the study was to examine the associations of …

Acinetobacter baumannii has emerged as a major cause of healthcare-associated
infections. Controversy exists as to whether antimicrobial resistance increases the risk of …

Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

Methods Yearly prevalence surveys (EPINE, Estudio de Prevalencia de las Infecciones
Nosocomiales en España) during 1999 to 2005 were analyzed, including data on the site of …

Objective Compare mortality in multidrug-susceptible Acinetobacter baumannii infected
patients and multidrug-resistant A. baumannii-infected patients hospitalized in intensive care …

Objective. To investigate the impact of antimicrobial resistance on clinical and economic
outcomes among hospitalized patients with multidrug-resistant (MDR) Acinetobacter …

This study aimed to evaluate the differences in clinical characteristics and impact of
carbapenem resistance (CR) on outcomes between Acinetobacter baumannii (Ab) and …

A retrospective case–control study was performed to assess risk factors and the clinical and
economic consequences associated with acquisition of carbapenem-resistant Acinetobacter …

Nosocomial Acinetobacter baumannii bloodstream infections occur with significant
prevalence and mortality. The relationship between carbapenem resistance in A. baumannii …

This retrospective study aims to compare differences in the medical costs between inpatients
infected/colonised with carbapenem-resistant (CRAB) and carbapenem-susceptible (CSAB) …